The autism risk genes MET and PLAUR differentially impact cortical development

Autism Research

Volumn 4, Issue 1, 2011, Pages 68-83

  Eagleson, Kathie L ^a   Campbell, Daniel B ^a   Thompson, Barbara L ^a   Bergman, Mica Y ^a,b,c   Levitt, Pat ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Animal models; Developmental neurobiology; Neuroanatomy

Indexed keywords

PROTEIN TYROSINE KINASE; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN DEVELOPMENT; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INTERNEURON; MOUSE; NEOCORTEX; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELENCEPHALON;

ALLELES; ANIMALS; CELL COUNT; CELL MOVEMENT; CEREBRAL CORTEX; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; HIPPOCAMPUS; HUMANS; IN SITU HYBRIDIZATION; INTERNEURONS; MALFORMATIONS OF CORTICAL DEVELOPMENT; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; PROTO-ONCOGENE PROTEINS C-MET; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 79951568560     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.172     Document Type: Article

References (101)

1. Abercrombie, M. (1946). Estimation of nuclear population from microtome sections. Anatomical Record, 94, 239-247.
2. Abrahams, B.S., & Geschwind, D.H. (2008). Advances in autism genetics: On the threshold of a new neurobiology. Nature Reviews Genetics, 9, 341-355.
3. Anderson, S.A., Eisenstat, D.D., Shi, L., & Rubenstein, J.L. (1997). Interneuron migration from basal forebrain to neocortex: Dependence on Dlx genes. Science, 278, 474-476.
4. Anderson, S.A., Marin, O., Horn, C., Jennings, K., & Rubenstein, J.L. (2001). Distinct cortical migrations from the medial and lateral ganglionic eminences. Development, 128, 353-363.
5. Bahi, A., Boyer, F., Kafri, T., & Dreyer, J.L. (2006). Silencing urokinase in the ventral tegmental area in vivo induces changes in cocaine-induced hyperlocomotion. Journal of Neurochemistry, 98, 1619-1631.
6. Beilmann, M., Vande Woude, G.F., Dienes, H.P., & Schirmacher, P. (2000). Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood, 95, 3964-3969.
7. Berghuis, P., Dobszay, M.B., Sousa, K.M., Schulte, G., Mager, P.P., et al. (2004). Brain-derived neurotrophic factor controls functional differentiation and microcircuit formation of selectively isolated fast-spiking GABAergic interneurons. European Journal of Neuroscience, 20, 1290-1306.
8. Bill, B.R., & Geschwind, D.H. (2009). Genetic advances in autism: Heterogeneity and convergence on shared pathways. Current Opinion in Genetics & Development, 19, 271-278.
9. Binder, B.R., Mihaly, J., & Prager, G.W. (2007). uPAR-uPA-PAI-1 interactions and signaling: A vascular biologist's view. Thrombosis & Haemostasis, 97, 336-342.
10. Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G.F. (2003). Met, metastasis, motility and more. Nature Reviews Molecular Cell Biology, 4, 915-925.
11. Bissonette, G.B., Bae, M.H., Suresh, T., Jaffe, D.E., & Powell, E.M. (2010). Astrocyte-mediated hepatocyte growth factor/scatter factor supplementation restores GABAergic interneurons and corrects reversal learning deficits in mice. Journal of Neuroscience, 30, 2918-2923.
12. Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995). Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature, 376, 768-771.
13. Blasi, F. (1993). Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness. Bioessays, 15, 105-111.
14. Campbell, D.B., Sutcliffe, J.S., Ebert, P.J., Militerni, R., Bravaccio, C., et al. (2006). A genetic variant that disrupts MET transcription is associated with autism. Proceedings of the National Academy of Sciences, USA, 103, 16834-16839.
15. Campbell, D.B., D'Oronzio, R., Garbett, K., Ebert, P.J., Mirnics, K., et al. (2007). Disruption of cerebral cortex MET signaling in autism spectrum disorder. Annals of Neurology, 62, 243-250.
16. Campbell, D.B., Li, C., Sutcliffe, J.S., Persico, A.M., & Levitt, P. (2008). Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Research, 1, 159-168.
17. Casanova, M.F., Buxhoeveden, D., & Gomez, J. (2003). Disruption in the inhibitory architecture of the cell minicolumn: Implications for autisim. Neuroscientist, 9, 496-507.
18. Cellerino, A., Maffei, L., & Domenici, L. (1996). The distribution of brain-derived neurotrophic factor and its receptor trkB in parvalbumin-containing neurons of the rat visual cortex. European Journal of Neuroscience, 8, 1190-1197.
19. Colombo, E.S., Menicucci, G., McGuire, P.G., & Das, A. (2007). Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression. Investigative Ophthalmology & Visual Science, 48, 1793-1800.
20. Courchesne, E., & Pierce, K. (2005). Why the frontal cortex in autism might be talking only to itself: Local over-connectivity but long-distance disconnection. Current Opinion in Neurobiology, 15, 225-230.
21. Del Bigio, M.R., Hosain, S., & Altumbabic, M. (1999). Localization of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse forebrain during postnatal development. International Journal of Developmental Neuroscience, 17, 387-399.
22. Dent, M.A., Sumi, Y., Morris, R.J., & Seeley, P.J. (1993). Urokinase-type plasminogen activator expression by neurons and oligodendrocytes during process outgrowth in developing rat brain. European Journal of Neuroscience, 5, 633-647.
23. Eagleson, K.L., Bonnin, A., & Levitt, P. (2005). Region- and age-specific deficits in gamma-aminobutyric acidergic neuron development in the telencephalon of the uPAR(-/-) mouse. Journal of Comparative Neurology, 489, 449-466.
24. Eagleson, K.L., Gravielle, M.C., Schlueter McFadyen-Ketchum, L.J., Russek, S.J., Farb, D.H., & Levitt, P. (2010). Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes. Neuroscience, 168, 797-810.
25. Ebens, A., Brose, K., Leonardo, E.D., Hanson, Jr., M.G., Bladt, F., et al. (1996). Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron, 17, 1157-1172.
26. Eckerich, C., Zapf, S., Fillbrandt, R., Loges, S., Westphal, M., & Lamszus, K. (2007). Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration. International Journal of Cancer, 121, 276-283.
27. El-Fishawy, P., & State, M.W. (2010). The genetics of autism: Key issues, recent findings, and clinical implications. The Psychiatric Clinics of North America, 33, 83-105.
28. Frith, C. (2004). Is autism a disconnection disorder? Lancet Neurology, 3, 577.
29. Geschwind, D.H. (2009). Advances in autism. Annual Review of Medicine, 60, 367-380.
30. Geschwind, D.H., & Levitt, P. (2007). Autism spectrum disorders: Developmental disconnection syndromes. Current Opinions in Neurobiology, 17, 103-111.
31. Giacobini, P., Messina, A., Wray, S., Giampietro, C., Crepaldi, T., et al. (2007). Hepatocyte growth factor acts as a motogen and guidance signal for gonadotropin hormone-releasing hormone-1 neuronal migration. Journal of Neuroscience, 27, 431-445.
32. Glasson, E.J., Bower, C., Petterson, B., de Klerk, N., Chaney, G., & Hallmayer, J.F. (2004). Perinatal factors and the development of autism: A population study. Archives of General Psychiatry, 61, 618-627.
33. Gorba, T., & Wahle, P. (1999). Expression of TrkB and TrkC but not BDNF mRNA in neurochemically identified interneurons in rat visual cortex in vivo and in organotypic cultures. European Journal of Neuroscience, 11, 1179-1190.
34. Hara, S., Nakashiro, K., Klosek, S.K., Ishikawa, T., Shintani, S., & Hamakawa, H. (2006a). Hypoxia enhances c-Met/HGF receptor expression and signaling by activating HIF-1alpha in human salivary gland cancer cells. Oral Oncology, 42, 593-598.
35. Hara, S., Nakashiro, K., Klosek, S.K., Ishikawa, T., Shintani, S., & Hamakawa, H. (2006b). Hypoxia enhances c-Met/HGF receptor expression and signaling by activating HIF-1alpha in human salivary gland cancer cells. Oral Oncolology, 42, 593-598.
36. Hayashi, M., Sakata, M., Takeda, T., Tahara, M., Yamamoto, T., et al. (2005). Up-regulation of c-met protooncogene product expression through hypoxia-inducible factor-1alpha is involved in trophoblast invasion under low-oxygen tension. Endocrinology, 146, 4682-4689.
37. Huang, Z.J., Kirkwood, A., Pizzorusso, T., Porciatti, V., Morales, B., et al. (1999). BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell, 98, 739-755.
38. Huh, C.G., Factor, V.M., Sanchez, A., Uchida, K., Conner, E.A., & Thorgeirsson, S.S. (2004). Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proceedings National Academy of Sciences, USA, 101, 4477-4482.
39. Ide, T., Kitajima, Y., Miyoshi, A., Ohtsuka, T., Mitsuno, M., et al. (2006). Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway. International Journal of Cancer, 119, 2750-2759.
40. Ide, T., Kitajima, Y., Miyoshi, A., Ohtsuka, T., Mitsuno, M., et al. (2007). The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling. Annals of Surgical Oncology, 14, 2600-2607.
41. Jackson, P.B., Boccuto, L., Skinner, C., Collins, J.S., Neri, G., et al. (2009). Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder. Autism Research, 2, 232-236.
42. Joannidis, M., Spokes, K., Nakamura, T., Faletto, D., & Cantley, L.G. (1994). Regional expression of hepatocyte growth factor/c-met in experimental renal hypertrophy and hyperplasia. American Journal of Physiology, 267, F231-F236.
43. Judson, M.C., Bergman, M.Y., Campbell, D.B., Eagleson, K.L., & Levitt, P. (2009). Dynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrain. Journal of Comparative Neurology, 513, 511-531.
44. Judson, M.C., Eagleson, K.L., Wang, L., & Levitt, P. (2010). Evidence of cell-nonautonomous changes in dendrite and dendritic spine morphology in the Met-signaling deficient mouse forebrain. Journal of Comparative Neurology, 518, 4463-4478.
45. Just, M.A., Cherkassky, V.L., Keller, T.A., Kana, R.K., & Minshew, N.J. (2007). Functional and anatomical cortical underconnectivity in autism: Evidence from an FMRI study of an executive function task and corpus callosum morphometry. Cerebral Cortex, 17, 951-961.
46. Jyonouchi, H., Geng, L., Ruby, A., & Zimmerman-Bier, B. (2005). Dysregulated innate immune responses in young children with autism spectrum disorders: Their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology, 51, 77-85.
47. Kinney, D.K., Munir, K.M., Crowley, D.J., & Miller, A.M. (2008). Prenatal stress and risk for autism. Neuroscience & Biobehavioral Reviews, 32, 1519-1532.
48. Kirchhofer, D., Yao, X., Peek, M., Eigenbrot, C., Lipari, M.T., et al. (2004). Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling. Journal of Biological Chemistry, 279, 39915-39924.
49. Kitamura, K., Iwanami, A., Nakamura, M., Yamane, J., Watanabe, K., et al. (2007). Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. Journal of Neuroscience Research, 85, 2332-2342.
50. Koga, F., Tsutsumi, S., & Neckers, L.M. (2007). Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells. Cell Cycle, 6, 1393-1402.
51. Kolevzon, A., Gross, R., & Reichenberg, A. (2007). Prenatal and perinatal risk factors for autism: A review and integration of findings. Archives of Pediatric & Adolescent Medicine, 161, 326-333.
52. Lahtinen, L., Huusko, N., Myohanen, H., Lehtivarjo, A.K., Pellinen, R., et al. (2009). Expression of urokinase-type plasminogen activator receptor is increased during epileptogenesis in the rat hippocampus. Neuroscience, 163, 316-328.
53. Lalive, P.H., Paglinawan, R., Biollaz, G., Kappos, E.A., Leone, D.P., et al. (2005). TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. European Journal of Immunology, 35, 727-737.
54. Larsson, H.J., Eaton, W.W., Madsen, K.M., Vestergaard, M., Olesen, A.V., et al. (2005). Risk factors for autism: Perinatal factors, parental psychiatric history, and socioeconomic status. American Journal of Epidemiology, 161, 916-925; discussion 926-918.
55. Lavdas, A.A., Grigoriou, M., Pachnis, V., & Parnavelas, J.G. (1999). The medial ganglionic eminence gives rise to a population of early neurons in the developing cerebral cortex. Journal of Neuroscience, 19, 7881-7888.
56. Levitt, P., & Campbell, D.B. (2009). The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. Journal of Clinical Investigations, 119, 747-754.
57. Levitt, P., Eagleson, K.L., & Powell, E.M. (2004). Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends in Neuroscience, 27, 400-406.
58. Lokker, N.A., Mark, M.R., Luis, E.A., Bennett, G.L., Robbins, K.A., et al. (1992). Structure-function analysis of hepatocyte growth factor: Identification of variants that lack mitogenic activity yet retain high affinity receptor binding. European Molecular Biology Organization Journal, 11, 2503-2510.
59. Longati, P., Bardelli, A., Ponzetto, C., Naldini, L., & Comoglio, P.M. (1994). Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene, 9, 49-57.
60. Mann, J.R., McDermott, S., Bao, H., Hardin, J., & Gregg, A. (2010). Pre-eclampsia, birth weight, and autism spectrum disorders. Journal of Autism and Developmental Disorders, 40, 548-554.
61. Mars, W.M., Zarnegar, R., & Michalopoulos, G.K. (1993). Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. American Journal of Pathology, 143, 949-958.
62. Marshall, C.R., Noor, A., Vincent, J.B., Lionel, A.C., Feuk, L., et al. (2008). Structural variation of chromosomes in autism spectrum disorder. American Journal of Human Genetics, 82, 477-488.
63. Martins, G.J., Plachez, C., & Powell, E.M. (2007). Loss of embryonic MET signaling alters profiles of hippocampal interneurons. Developmental Neuroscience, 29, 143-158.
64. Masos, T., & Miskin, R. (1996). Localization of urokinase-type plasminogen activator mRNA in the adult mouse brain. Molecular Brain Research, 35, 139-148.
65. Meiri, N., Masos, T., Rosenblum, K., Miskin, R., & Dudai, Y. (1994). Overexpression of urokinase-type plasminogen activator in transgenic mice is correlated with impaired learning. Proceedings National Academy of Sciences, USA, 91, 3196-3200.
66. Minshew, N.J., & Williams, D.L. (2007). The new neurobiology of autism: Cortex, connectivity, and neuronal organization. Archives of Neurology, 64, 945-950.
67. Nagayama, T., Nagayama, M., Kohara, S., Kamiguchi, H., Shibuya, M., et al. (2004). Post-ischemic delayed expression of hepatocyte growth factor and c-Met in mouse brain following focal cerebral ischemia. Brain Research, 999, 155-166.
68. Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H., & Nakamura, T. (2000). Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. Journal of Clinical Investigations, 106, 1511-1519.
69. Naldini, L., Tamagnone, L., Vigna, E., Sachs, M., Hartmann, G., et al. (1992). Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. European Molecular Biology Organization Journal, 11, 4825-4833.
70. Okunishi, K., Dohi, M., Nakagome, K., Tanaka, R., Mizuno, S., et al. (2005). A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. Journal of Immunology, 175, 4745-4753.
71. Okura, Y., Arimoto, H., Tanuma, N., Matsumoto, K., Nakamura, T., et al. (1999). Analysis of neurotrophic effects of hepatocyte growth factor in the adult hypoglossal nerve axotomy model. European Journal of Neuroscience, 11, 4139-4144.
72. Orzechowski, A. (2007). Possible implications of redox-sensitive tumour cell transformation; lessons from cell culture studies. Polish Journal of Veterinary Sciences, 10, 123-126.
73. Owen, K.A., Qiu, D., Alves, J., Schumacher, A.M., Kilpatrick, L.M., et al. (2010). Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA. Biochemistry Journal, 426, 219-228.
74. Patz, S., Grabert, J., Gorba, T., Wirth, M.J., & Wahle, P. (2004). Parvalbumin expression in visual cortical interneurons depends on neuronal activity and TrkB ligands during an Early period of postnatal development. Cerebral Cortex, 14, 342-351.
75. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., & Comoglio, P.M. (2003). Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell, 3, 347-361.
76. Pleasure, S.J., Anderson, S., Hevner, R., Bagri, A., Marin, O., et al. (2000). Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons. Neuron, 28, 727-740.
77. Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., et al. (1994). A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell, 77, 261-271.
78. Powell, E.M., Mars, W.M., & Levitt, P. (2001). Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron, 30, 79-89.
79. Powell, E.M., Campbell, D.B., Stanwood, G.D., Davis, C., Noebels, J.L., & Levitt, P. (2003a). Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. Journal of Neuroscience, 23, 622-631.
80. Powell, E.M., Muhlfriedel, S., Bolz, J., & Levitt, P. (2003b). Differential regulation of thalamic and cortical axonal growth by hepatocyte growth factor/scatter factor. Developmental Neuroscience, 25, 197-206.
81. Rabkin, R., Fervenza, F., Tsao, T., Sibley, R., Friedlaender, M., et al. (2001). Hepatocyte growth factor receptor in acute tubular necrosis. Journal of the American Society of Nephrology, 12, 531-540.
82. Rosova, I., Dao, M., Capoccia, B., Link, D., & Nolta, J.A. (2008). Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells, 26, 2173-2182.
83. Rubenstein, J.L. (2010). Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Current Opinion in Neurology, 23, 118-123.
84. Rubenstein, J.L., & Merzenich, M.M. (2003). Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes Brain & Behavior, 2, 255-267.
85. Scarpino, S., Cancellario d'Alena, F., Di Napoli, A., Pasquini, A., Marzullo, A., & Ruco, L.P. (2004). Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid. Journal of Pathology, 202, 352-358.
86. Shimazaki, K., Yoshida, K., Hirose, Y., Ishimori, H., Katayama, M., & Kawase, T. (2003). Cytokines regulate c-Met expression in cultured astrocytes. Brain Research, 962, 105-110.
87. Sousa, I., Clark, T.G., Toma, C., Kobayashi, K., Choma, M., et al. (2009). MET and autism susceptibility: Family and case-control studies. European Journal of Human Genetics, 17, 749-758.
88. Stefan, M., Koch, A., Mancini, A., Mohr, A., Weidner, K.M., et al. (2001). Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis. Journal of Biological Chemistry, 276, 3017-3023.
89. Stenman, J., Toresson, H., & Campbell, K. (2003). Identification of two distinct progenitor populations in the lateral ganglionic eminence: Implications for striatal and olfactory bulb neurogenesis. Journal of Neuroscience, 23, 167-174.
90. Sussel, L., Marin, O., Kimura, S., & Rubenstein, J.L. (1999). Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: Evidence for a transformation of the pallidum into the striatum. Development, 126, 3359-3370.
91. Tang, C.H., & Wei, Y. (2008). The urokinase receptor and integrins in cancer progression. Cellular & Molecular Life Sciences, 65, 1916-1932.
92. Thompson, B.L., Stanwood, G.D., & Levitt, P. (2010). Specificity of prenatal cocaine exposure effects on cortical interneurons is independent from dopamine D1 receptor co-localization. Journal of Chemical Neuroanatomy, 39, 228-234.
93. Tuchman, R., & Rapin, I. (2002). Epilepsy in autism. Lancet Neurology, 1, 352-358.
94. Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., et al. (1995). Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature, 373, 702-705.
95. Vaccarino, F.M., Grigorenko, E.L., Smith, K.M., & Stevens, H.E. (2009). Regulation of cerebral cortical size and neuron number by fibroblast growth factors: Implications for autism. Journal of Autism and Developmental Disorders, 39, 511-520.
96. Valicenti-McDermott, M., McVicar, K., Rapin, I., Wershil, B.K., Cohen, H., & Shinnar, S. (2006). Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. Journal of Developmental and Behavioral Pediatrics, 27, S128-136.
97. van Handel, M., Swaab, H., de Vries, L.S., & Jongmans, M.J. (2007). Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: A review. European Journal of Pediatrics, 166, 645-654.
98. Wichterle, H., Garcia-Verdugo, J.M., Herrera, D.G., & Alvarez-Buylla, A. (1999). Young neurons from medial ganglionic eminence disperse in adult and embryonic brain. Nature Neuroscience, 2, 461-466.
99. Wilkerson, D.S., Volpe, A.G., Dean, R.S., & Titus, J.B. (2002). Perinatal complications as predictors of infantile autism. International Journal of Neuroscience, 112, 1085-1098.
100. Xiao, G.H., Jeffers, M., Bellacosa, A., Mitsuuchi, Y., Vande Woude, G.F., & Testa, J.R. (2001). Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proceedings of the National Academy of Sciences, USA, 98, 247-252.
101. Yoshida, S., & Shiosaka, S. (1999). Plasticity-related serine proteases in the brain (review). International Journal of Molecular Medicine, 3, 405-409.